News

Cystic Fibrosis Foundation Grants $1.8 million to Expand the Atlanta CF Research and Development Program

Children’s Healthcare of Atlanta, Emory University, and Georgia Tech were recently awarded a grant by The Cystic Fibrosis Foundation to expand the Atlanta CF Research and Development Program (CF@LANTA RDP Program). The four-year grant worth $1.8 million will enable the collaborating institutions to expand their current cystic fibrosis research projects and translate…

Spyryx Biosciences Receives Award From Cystic Fibrosis Foundation Therapeutics

Spyryx Biosciences, Inc., a private bio-pharmaceutical firm advancing new therapeutics to address obstructive lung diseases, recently announced it has received an award from Cystic Fibrosis Foundation Therapeutics that will provide support to the development of Spyryx’s therapeutic peptides to address cystic fibrosis. “We appreciate the generous support of the Cystic Fibrosis…

miRNAs Offer Potential New Targets for Cystic Fibrosis Gene Therapy

A new study revealed that microRNA16 — a small non-coding RNA genes that regulates gene expression — can restore the F508del-CFTR protein function in airway cell lines and primary cultures of differentiated human bronchial epithelia from F508del homozygotes that express mutant CFTR protein endogenously. The finding is significant, as…

Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.